[1]王红艳,陈红*邹阳,潘虹,等.宫腔镜下子宫内膜息肉切除术后不同处理对息肉复发的影响[J].中国微创外科杂志,2013,13(6):500-505.
 Wang Hongyan,Chen Hong,Zou Yang,et al.The Clinical Effects of Different Treatments after Transcervical Resection of Polyps on Recurrence of Endometrial Polyps[J].Chinese Journal of Minimally Invasive Surgery,2013,13(6):500-505.
点击复制

宫腔镜下子宫内膜息肉切除术后不同处理对息肉复发的影响()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
13
期数:
2013年6期
页码:
500-505
栏目:
出版日期:
2013-06-20

文章信息/Info

Title:
The Clinical Effects of Different Treatments after Transcervical Resection of Polyps on Recurrence of Endometrial Polyps
作者:
王红艳陈红*邹阳潘虹周秀红
武汉大学中南医院妇产科,武汉430071
Author(s):
Wang Hongyan Chen Hong Zou Yang et al.
Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
关键词:
子宫内膜息肉宫腔镜复发安宫黄体酮曼月乐
Keywords:
Endometrial polypHysteroscopyRecurrenceMedroxyprogesteroneLevonorgestrelreleasing intrauterine system(LNGIUS)
分类号:
R711.74
文献标志码:
A
摘要:
目的比较宫腔镜下子宫内膜息肉切除术(transcervical resection of polyps,TCRP)后口服安宫黄体酮及宫腔放置曼月乐预防子宫内膜息肉(endometrial polyps, EP)复发的疗效。方法2009年1月~2011年1月92例TCRP术后根据治疗方法不同分为3组,对照组30例,安宫黄体酮组32例,曼月乐组30例,比较3组EP复发及子宫异常出血的改善情况。结果曼月乐组术后EP复发率为0,显著低于对照组16.7%(5/30)和安宫黄体酮组12.5%(4/32)(Z=-2.316,P=0021;Z=-1.986,P=0.047),安宫黄体酮组与对照组EP复发率无统计学差异(Z=-0.462,P=0.644)。3组子宫异常出血改善情况无统计学差异(χ2=0.362,P=0.834)。结论TCRP术后宫腔放置曼月乐可有效预防EP复发,口服安宫黄体酮不能降低EP复发率。
Abstract:
ObjectiveTo compare the curative effects of oral administration of medroxyprogesterone acetate and the placement of LNIUS into uterine cavity on the prevention of recurrence of endometrial polyps (EP) after transcervical resection of polyps (TCRP).MethodsFrom January 2009 to January 2011, 92 patients with EP were divided into 3 groups according to different treatments after TCRP: 30 cases in control group, 32 cases in medroxyprogesterone group and 30 cases in LNIUS group. The recurrence of EP and the improvement of abnormal hemorrhage were compared among the three groups. ResultsThe recurrence rate of the LNIUS group was 0, significantly lower than that of the control group 16.7% (5/30) and the medroxyprogesterone group 125%(4/32) (Z=-2.316,P=0.021;Z=-1.986,P=0.047). No significant difference could be found in the recurrence rate of EP between control group and medroxyprogesterone group(Z=-0.462,P=0.644). No significant difference among the three groups was observed in the improvement of abnormal hemorrhage(χ2=0.362,P=0.834).ConclusionThe placement of LNIUS into uterine cavity after TCRP can effectively prevent the recurrence of EP, while oral administration of medroxyprogesterone acetate cannot reduce the recurrence rate of EP.

参考文献/References:

[1]夏恩兰,主编.妇科内镜学.北京:人民卫生出版社,2004.130-131.
[2]邓玉清,吴瑞芳,王玉洁,等.宫腔镜手术联合孕激素诊治子宫内膜息肉的临床分析.实用医技杂志,2008,15(31):4331-4332.
[3]汤惠茹,王丽平,陈晓琳.等.子宫内膜息肉的手术治疗及术后复发的预防.中国妇产科临床杂志,2011,11(3):182-184.
[4]孙华,张勇,郑健.宫腔镜治疗黏膜下子宫肌瘤72例.中国微创外科杂志,2005,5(3):198-199.
[5]Rahimi S, Marani C, Renzi C, et al. Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol,2009,28:522-528.
[6]商敏, 蔺莉.宫腔镜诊治子宫内膜息肉122例临床分析.中国微创外科杂志,2011,11:903-905.
[7]Spiewankiewicz B, Stelmachow J, Sawicki W, et al. The effectiveness of hysteroscopic polypectomy in cases of female infertility. Clin Exp Obstet Gynecol,2003,30(1):23-25.
[8]Peng X, Li T, Xia E, et al. A comparison of oestrogen receptor and progesterone receptor expression in endometrial polyps and endometrium of premenopausal women. J Obstet Gynecol,2009,29:340-346.
[9]Gardner FJ, Konje JC, Abrams KR, et al. Endometrial protection from tamoxifenstimulated changes by a levonorgestrelreleasing intrauterine system: a randomized controlled trial. Lancet,2000,356(9243):1711-1717.
[10]Lete C, Obispo F, Izaguirre T. The levonorgestrelreleasing intrauterine system(Mirena) for treatment of idiopathic menorrhagia. Eur J Contracep Repr,2008,13(3):231-237.
[11]Mcgavigan CJ, Dockery P, Metaxa MV, et al. Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgesterl. Hum Report,2003,18(1):77-84.

备注/Memo

备注/Memo:
*通讯作者,Email:chen.hong888@126.com
更新日期/Last Update: 2014-01-08